Overview

NAT2 in Re-challenge of INH in Patients With Hepatitis

Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Apply the information of NAT2 genotyping into the re-challenge protocol of INH titration in patients with anti-TB medication induced hepatitis.
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Treatments:
Isoniazid